Striatal Dopamine D(2/3) Receptor Availability in Treatment Resistant Depression

Several studies demonstrated improvement of depressive symptoms in treatment resistant depression (TRD) after administering dopamine agonists which suggest abnormal dopaminergic neurotransmission in TRD. However, the role of dopaminergic signaling through measurement of striatal dopamine D(2/3) rece...

Descripción completa

Detalles Bibliográficos
Autores principales: de Kwaasteniet, Bart P., Pinto, Chedwa, Ruhé, Eric H. G., van Wingen, Guido A., Booij, Jan, Denys, Damiaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239080/
https://www.ncbi.nlm.nih.gov/pubmed/25411966
http://dx.doi.org/10.1371/journal.pone.0113612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239080/
https://www.ncbi.nlm.nih.gov/pubmed/25411966
http://dx.doi.org/10.1371/journal.pone.0113612

Ejemplares similares